Keld Ibsen

Chief Executive Officer, CARECONSULT A/S

Johs.Ewalds Vej 113 active roles

Keld Ibsen holds 3 active roles in Danish companies registered in CVR, including Chief Executive Officer at CARECONSULT A/S since 2010 and Management at MedicCare A/S since 2025. Keld Ibsen is registered as legal owner of XIPHIAS INVEST ApS (100% share band).

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

Career timeline

2025 – now
Management, MedicCare A/S
2010 – now
Management, XIPHIAS INVEST ApS
2010 – now
Chief Executive Officer, CARECONSULT A/S

Personal details

Address

Johs.Ewalds Vej 11

Companies & roles

Active roles

3 positions

Company	Role	Period	Ownership	Status
XIPHIAS INVEST ApS CVR 32671195	ManagementManagement	Since 2010	100%	Active
MedicCare A/S CVR 45506282	ManagementManagement	Since 2025	—	Active
CARECONSULT A/S CVR 25483537	ManagementChief Executive Officer	Since 2010	—	Active

Network

Company network

Active roles

Keld Ibsen

Chief Executive Officer

Co-directors & shared companies

Person	Role	Shared companies	Profile
PB Palle Bo Niss	Board of Directors	2companies	View profile
BL Bjarne Lund	Board of Directors	1company	View profile
MV Mikkel Viggers	Board of Directors	1company	View profile
BM Bertel Mollerup	Founder	1company	View profile

Is this you? About the data on this page

This profile is compiled automatically from CVR / Virk, the official business register in Denmark. Riskpilot is operated by Risika A/S, which is the data controller for this page. We don't add private information — only the roles and details the register itself publishes.

Because this is public register data, it can't be erased — corrections to the underlying record are made with the register, and we pick them up once they're published. You do have the right to object to how your details are shown here, and we can de-index this profile so it no longer appears in search engines such as Google.

To make a request, email privacy@risika.com with a link to this page. We respond within 30 days. Read more in our privacy policy.